Community
Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
Weekly Picks
BE
Bejgal
Community Contributor
Fiverr aims for greater revenue with expansive enterprise solutions and AI
Catalysts Fiverr International’s introduction of AI-powered tools such as Dynamic Matching and Neo (AI-powered smart matching) is expected to significantly enhance sales and earnings. These tools cater to businesses requiring tailored and complex projects, leading to larger transactions.
View narrativeUS$105.21
FV
74.7% undervalued intrinsic discount12.30%
Revenue growth p.a.
15users have liked this narrative
0users have commented on this narrative
63users have followed this narrative
11 days ago author updated this narrative
ST
Equity Analyst and Writer
SoundHound’s Moat And Diversified Revenue Strategy Make It A Voice AI Leader
Key Points SoundHound has developed over two decades of moat in an industry that just started getting traction. With shrinking electronics and communication with machines becoming more mainstream, I believe the company can capture much of this growth.
View narrativeUS$28.58
FV
67.0% undervalued intrinsic discount139.00%
Revenue growth p.a.
67users have liked this narrative
0users have commented on this narrative
145users have followed this narrative
4 days ago author updated this narrative
EV
Evangelos
Community Contributor
Medtronic Stock: A Compelling Buy for Value and Income Investors as Robotics, Innovation Catalysts Ignite Upside to $105+
Strengths and Competitive Advantages: Diverse Product Portfolio: Medtronic operates across four key segments—Cardiovascular, Medical-Surgical, Neuroscience, and Diabetes—providing revenue stability and reducing dependency on any single product line. This diversification surpasses more specialized competitors like Boston Scientific (focused on cardiovascular) or Intuitive Surgical (robotics).
View narrativeUS$95.00
FV
5.1% undervalued intrinsic discount5.15%
Revenue growth p.a.
9users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
7 days ago author updated this narrative
WA
Consensus Narrative from 3 Analysts
Expanded Milling And Sustainability Efforts Will Shape Future Operations
Key Takeaways Increasing milling capacity and acquiring new properties aim to boost production efficiency and expand revenue streams through enhanced operational scale. Focus on sustainability and strategic acquisitions are expected to attract premium buyers, grow earnings, and support share buybacks, improving EPS.
View narrativeUK£13.05
FV
18.4% undervalued intrinsic discount3.73%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
13 days ago author updated this narrative
WA
Consensus Narrative from 41 Analysts
Topaz Will Deepen AI Capabilities, Building Generative AI Agents For Future Transformations
Key Takeaways Deepening enterprise AI capabilities and large deal wins suggest future growth and expanded offerings in high-demand technology areas. Focus on cost optimization and strategic growth measures is expected to enhance margins and profitability.
View narrative₹2.11k
FV
16.3% undervalued intrinsic discount8.08%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
13 days ago author updated this narrative
WA
Consensus Narrative from 11 Analysts
Palmerton Expansion And Cost Reductions Will Improve US Zinc Recycling Operations
Key Takeaways Befesa anticipates significant EBITDA growth from improved zinc hedging, expanded U.S. recycling, and cost reductions in zinc refining operations. Strategic investments in capacity expansion and low-risk projects are poised to enhance revenue stability, capturing market growth.
View narrative€33.00
FV
31.3% undervalued intrinsic discount6.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
13 days ago author updated this narrative
WA
Consensus Narrative from 1 Analyst
New Game Releases And Cost Optimizations Will Lead To Positive Outcomes In 2025
Key Takeaways Business optimizations and cost reductions are expected to enhance profitability margins and earnings, with significant savings anticipated from winding down Toadman operations. EG7 aims to drive growth through key game releases, leveraging long life cycle IPs for predictable revenue, and maintaining strong liquidity without debt.
View narrativeSEK 38.00
FV
65.7% undervalued intrinsic discount7.69%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
13 days ago author updated this narrative
WA
Consensus Narrative from 3 Analysts
Consolidation Of Pricewise And Azimut Partnership May Strengthen Future Outlook
Key Takeaways Expanding mortgage market recovery and international comparisons consolidation may drive revenue growth significantly. Strong leasing operations and increased service demand in claims could boost revenue and operating margins.
View narrative€46.90
FV
22.6% undervalued intrinsic discount7.16%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
13 days ago author updated this narrative
WA
Consensus Narrative from 9 Analysts
Expansion In US Insurance Platforms Will Improve Competitive Positioning
Key Takeaways Expanding U.S. operations and building distribution relationships could drive premium growth and revenue increases. Strategic asset redeployment and a growing equity base promise better market access, competitive positioning, and sustained operating income growth.
View narrativeCA$53.11
FV
35.1% undervalued intrinsic discount8.47%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
13 days ago author updated this narrative
WA
Consensus Narrative from 1 Analyst
Investment In GLP-1 Drug Production Will Unlock New Profit Streams In 2025
Key Takeaways Strategic investments in GLP-1 drug compounding and new food products suggest significant future revenue potential in pharmaceuticals and nutraceuticals. Divestment and operational consolidation are expected to improve future earnings and net margins through efficiency gains.
View narrativeUS$9.00
FV
34.9% undervalued intrinsic discount27.32%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
13 days ago author updated this narrative
WA
Consensus Narrative from 1 Analyst
Launching NT-proBNP Test And Expanding Partnerships Will Broaden Cardiology Portfolio
Key Takeaways Strategic partnerships and continual global expansion enhance Gentian's market presence and drive revenue growth. Focus on new product development and improved financial margins suggests future growth and operating efficiency.
View narrativeNOK 67.00
FV
30.4% undervalued intrinsic discount26.05%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
13 days ago author updated this narrative
WA
Consensus Narrative from 5 Analysts
Acquisitions And Operational Efficiencies Will Support Future Earnings
Key Takeaways Recent acquisitions and facility expansions indicate potential revenue growth through increased production capacity and market reach. Strategic debt management and improved factory efficiencies enhance gross margins, supporting long-term earnings growth and profitability.
View narrativeSEK 102.80
FV
17.4% undervalued intrinsic discount4.82%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
13 days ago author updated this narrative